Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Apyx Medical (APYX) over the last 14 years, with Q3 2025 value amounting to $51.0 million.

  • Apyx Medical's Total Non-Current Liabilities rose 338.38% to $51.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $51.0 million, marking a year-over-year increase of 338.38%. This contributed to the annual value of $50.2 million for FY2024, which is 359.17% down from last year.
  • Per Apyx Medical's latest filing, its Total Non-Current Liabilities stood at $51.0 million for Q3 2025, which was up 338.38% from $50.4 million recorded in Q2 2025.
  • In the past 5 years, Apyx Medical's Total Non-Current Liabilities registered a high of $52.1 million during Q4 2023, and its lowest value of $10.8 million during Q1 2021.
  • Over the past 5 years, Apyx Medical's median Total Non-Current Liabilities value was $25.5 million (recorded in 2023), while the average stood at $30.4 million.
  • As far as peak fluctuations go, Apyx Medical's Total Non-Current Liabilities tumbled by 512.17% in 2022, and later soared by 27765.38% in 2023.
  • Apyx Medical's Total Non-Current Liabilities (Quarter) stood at $14.5 million in 2021, then decreased by 5.12% to $13.8 million in 2022, then soared by 277.65% to $52.1 million in 2023, then dropped by 3.59% to $50.2 million in 2024, then grew by 1.48% to $51.0 million in 2025.
  • Its Total Non-Current Liabilities was $51.0 million in Q3 2025, compared to $50.4 million in Q2 2025 and $49.2 million in Q1 2025.